Significantly Increased Patient Satisfaction Following Liquid Formulation AbobotulinumtoxinA Treatment in Glabellar Lines: FACE-Q Outcomes From a Phase 3 Clinical Trial.

Ascher, Benjamin; Rzany, Berthold; Kestemont, Philippe; Hilton, Said; Heckmann, Marc; Bodokh, Isaac; Noah, Ernst Magnus; Boineau, Dominique; Kerscher, Martina; Volteau, Magali; Le Berre, Philippe; Picaut, Philippe

Ascher, Benjamin; Rzany, Berthold; Kestemont, Philippe; Hilton, Said; Heckmann, Marc; Bodokh, Isaac; Noah, Ernst Magnus; Boineau, Dominique; Kerscher, Martina; Volteau, Magali; Le Berre, Philippe; Picaut, Philippe.

Affiliation

Ascher B; Iena Plastic Surgery Clinic, Paris, France.
Rzany B; Rzany and Hund, Berlin, Germany.
Kestemont P; Mediti Centre, Antibes-Juan Les Pins, France.
Hilton S; Dr. Hilton & Partner, Düsseldorf, Germany.
Heckmann M; Starnberg Skin Centre, Starnberg, Germany.
Bodokh I; Dermatology Department, Cannes Hospital, Cannes, France.
Noah EM; Division of Plastic and Reconstructive Surgery, Red Cross Hospital, Kassel, Germany.
Boineau D; Clinique Chirurgicale Bel-Air, Bordeaux, France.
Kerscher M; Division of Cosmetic Science, Department of Chemistry, University of Hamburg, Hamburg, Germany.
Volteau M; Neurology Development, Ipsen Innovation, Les Ulis, Paris, France.
Le Berre P; Neurology Development, Ipsen Innovation, Les Ulis, Paris, France.
Picaut P; Neurology Development, Ipsen Innovation, Les Ulis, Paris, France.

Aesthet Surg J ; 40(9): 1000-1008, 2020 08 14.

Article in En | MEDLINE | ID: mdl-31550352

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Aging / Botulinum Toxins, Type A Type of study: Clinical_trials Aspects: Patient_preference Limits: Adult / Humans Language: En Journal: Aesthet Surg J Year: 2020 Document type: Article Affiliation country: Francia Country of publication: Reino Unido

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google